Cite
HARVARD Citation
Bocchia, M. et al. (2019). Real‐world experience with decitabine as a first‐line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy. Hematological oncology. 37 (4), pp. 447-455. [Online].